Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 1/2015

01.03.2015 | Review Article

CNS Involvement in Pancreatic Adenocarcinoma: a Report of Eight Cases from the Johns Hopkins Hospital and Review of Literature

verfasst von: Abhijeet Kumar, Meenakshi Dagar, Joseph Herman, Christine Iacobuzio-Donahue, Dan Laheru

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

CNS metastasis of pancreatic cancer is extremely rare, although systemic metastasis is very common. We present eight such cases with various forms of nervous system involvement.

Methods

Data was gathered from chart review of 800 patients with pancreatic cancer treated between 2004 and 2012 of which eight patients are described with CNS metastases.

Results

The median age of patients was 61.5 years and the median time to develop CNS metastasis was 29 months. Interestingly, two patients had no other sites of metastasis. The treatment modalities tried included resection followed by radiation, resection alone, or whole brain radiation.
Literatur
2.
Zurück zum Zitat American Cancer society. Cancer facts and figures. Atlanta, GA; 2012. American Cancer society. Cancer facts and figures. Atlanta, GA; 2012.
3.
Zurück zum Zitat Lee YT, Tatter D. Carcinoma of the pancreas and periampullary structures pattern of metastasis at autopsy. Arch Pathol Lab Med. 1984;108(7):584–7.PubMed Lee YT, Tatter D. Carcinoma of the pancreas and periampullary structures pattern of metastasis at autopsy. Arch Pathol Lab Med. 1984;108(7):584–7.PubMed
4.
Zurück zum Zitat Go PH, Klaassen Z, Meadows MC, Chamberlain RS. Gastrointestinal cancer and brain metastasis: a rare and ominous sign. Cancer. 2011;117(16):3630–40.CrossRefPubMed Go PH, Klaassen Z, Meadows MC, Chamberlain RS. Gastrointestinal cancer and brain metastasis: a rare and ominous sign. Cancer. 2011;117(16):3630–40.CrossRefPubMed
5.
Zurück zum Zitat Park KS, Kim M, Park SH, Lee KW. Nervous system involvement by pancreatic cancer. J Neurooncol. 2003;63(3):313–6.CrossRefPubMed Park KS, Kim M, Park SH, Lee KW. Nervous system involvement by pancreatic cancer. J Neurooncol. 2003;63(3):313–6.CrossRefPubMed
6.
Zurück zum Zitat Iacobuzio-Donahue CA, Fu B, Yachida S, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27(11):1806–13.CrossRefPubMedCentralPubMed Iacobuzio-Donahue CA, Fu B, Yachida S, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27(11):1806–13.CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Mihaljevic AL, Michalski CW, Friess H, Kleeff J. Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg. 2010;395(4):295–308.CrossRefPubMed Mihaljevic AL, Michalski CW, Friess H, Kleeff J. Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg. 2010;395(4):295–308.CrossRefPubMed
8.
Zurück zum Zitat Abiatari I, DeOliveira T, Kerkadze V, et al. Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. Mol Cancer Ther. 2009;8(6):1494–504.CrossRefPubMed Abiatari I, DeOliveira T, Kerkadze V, et al. Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. Mol Cancer Ther. 2009;8(6):1494–504.CrossRefPubMed
9.
Zurück zum Zitat Matsumura T, Ohzato H, Yamamoto T, et al. A case of postoperative brain metastasis originated from pancreatic cancer which was successfully treated by resection and postoperative irradiation. Gan To Kagaku Ryoho. 2009;36(12):2433–5.PubMed Matsumura T, Ohzato H, Yamamoto T, et al. A case of postoperative brain metastasis originated from pancreatic cancer which was successfully treated by resection and postoperative irradiation. Gan To Kagaku Ryoho. 2009;36(12):2433–5.PubMed
10.
Zurück zum Zitat Abe T, Oshida K, Matsumoto K, Iida M, Sanno N. Brain metastasis from malignant pancreatic somatostatinoma case report. J Neurosurg. 1996;85(4):681–4.CrossRefPubMed Abe T, Oshida K, Matsumoto K, Iida M, Sanno N. Brain metastasis from malignant pancreatic somatostatinoma case report. J Neurosurg. 1996;85(4):681–4.CrossRefPubMed
11.
Zurück zum Zitat Ara Callizo JR, Gimenez-Mas JA, Martin J, Lacasa J. Calcified brain metastases from acinar-cell carcinoma of pancreas. Neuroradiology. 1989;31(2):200.CrossRefPubMed Ara Callizo JR, Gimenez-Mas JA, Martin J, Lacasa J. Calcified brain metastases from acinar-cell carcinoma of pancreas. Neuroradiology. 1989;31(2):200.CrossRefPubMed
12.
Zurück zum Zitat Vaccaro V, Sperduti I, Milella M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;365(8):768–9. author reply 769.CrossRefPubMed Vaccaro V, Sperduti I, Milella M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;365(8):768–9. author reply 769.CrossRefPubMed
13.
Zurück zum Zitat Shah SU, Shields CL, Bianciotto CG, Shields JA. Pancreatic cancer metastasis to choroid. Ophthalmology. 2011;118(7):1483.PubMed Shah SU, Shields CL, Bianciotto CG, Shields JA. Pancreatic cancer metastasis to choroid. Ophthalmology. 2011;118(7):1483.PubMed
14.
Zurück zum Zitat Lin CJ, Yang CM, Chen MS. Intraocular metastasis of pancreatic cancer: report of two cases. Retina. 2001;21(6):666–9.CrossRefPubMed Lin CJ, Yang CM, Chen MS. Intraocular metastasis of pancreatic cancer: report of two cases. Retina. 2001;21(6):666–9.CrossRefPubMed
15.
Zurück zum Zitat Nasser M, Haj M, Nassar F. Carcinoma of pancreas presenting as a decrease in visual acuity. Hepatogastroenterology. 2002;49(44):558–60.PubMed Nasser M, Haj M, Nassar F. Carcinoma of pancreas presenting as a decrease in visual acuity. Hepatogastroenterology. 2002;49(44):558–60.PubMed
16.
Zurück zum Zitat Castillo J, Ascaso FJ, Aguelo JM, Minguez E, Cristobal JA, Palomar A. Bilateral choroidal metastases of pancreatic carcinoma. J Fr Ophtalmol. 1995;18(12):795–8.PubMed Castillo J, Ascaso FJ, Aguelo JM, Minguez E, Cristobal JA, Palomar A. Bilateral choroidal metastases of pancreatic carcinoma. J Fr Ophtalmol. 1995;18(12):795–8.PubMed
17.
Zurück zum Zitat Caricato M, Borzomati D, Ausania F, et al. Cerebellar metastasis from pancreatic adenocarcinoma. A case report. Pancreatology. 2006;6(4):306–8.CrossRefPubMed Caricato M, Borzomati D, Ausania F, et al. Cerebellar metastasis from pancreatic adenocarcinoma. A case report. Pancreatology. 2006;6(4):306–8.CrossRefPubMed
18.
Zurück zum Zitat El Kamar FG, Jindal K, Grossbard ML, Mizrachi HH, Kozuch PS. Pancreatic carcinoma with brain metastases: case report and literature review. Dig Liver Dis. 2004;36(5):355–60.CrossRefPubMed El Kamar FG, Jindal K, Grossbard ML, Mizrachi HH, Kozuch PS. Pancreatic carcinoma with brain metastases: case report and literature review. Dig Liver Dis. 2004;36(5):355–60.CrossRefPubMed
19.
Zurück zum Zitat Demchuk AI. Clinical picture and diagnosis of metastatic brain cancer with its primary source in the pancreas. Vrach Delo. 1977;11:38–41.PubMed Demchuk AI. Clinical picture and diagnosis of metastatic brain cancer with its primary source in the pancreas. Vrach Delo. 1977;11:38–41.PubMed
20.
Zurück zum Zitat Ferreira Montero V, Eiras Ajuria J, Gomez Pereda R, Montori Lasilla M, Valero Palomero MI. Cerebral metastasis, idiopathic pneumoperitoneum and obstructive jaundice as clinical manifestations of carcinoma of the pancreas. Rev Esp Oncol. 1983;30(3):399–409.PubMed Ferreira Montero V, Eiras Ajuria J, Gomez Pereda R, Montori Lasilla M, Valero Palomero MI. Cerebral metastasis, idiopathic pneumoperitoneum and obstructive jaundice as clinical manifestations of carcinoma of the pancreas. Rev Esp Oncol. 1983;30(3):399–409.PubMed
21.
Zurück zum Zitat Kuratsu J, Murakami M, Uemura S, Ushio Y. Brain and skull metastases of hepatic or pancreatic cancer—report of six cases. Neurol Med Chir (Tokyo). 1990;30(7):476–82.CrossRef Kuratsu J, Murakami M, Uemura S, Ushio Y. Brain and skull metastases of hepatic or pancreatic cancer—report of six cases. Neurol Med Chir (Tokyo). 1990;30(7):476–82.CrossRef
22.
Zurück zum Zitat Shangai VA, Gavrik I. Metastasis of pancreatic cancer to the brain. Vrach Delo. 1984;11:77–9.PubMed Shangai VA, Gavrik I. Metastasis of pancreatic cancer to the brain. Vrach Delo. 1984;11:77–9.PubMed
23.
Zurück zum Zitat Yamada K, Miura M, Miyayama H, Sakashita N, Kochi M, Ushio Y. Brain metastases from asymptomatic adenocarcinoma of the pancreas: an autopsy case report. Surg Neurol. 2002;58(5):332–6. discussion 336–7.CrossRefPubMed Yamada K, Miura M, Miyayama H, Sakashita N, Kochi M, Ushio Y. Brain metastases from asymptomatic adenocarcinoma of the pancreas: an autopsy case report. Surg Neurol. 2002;58(5):332–6. discussion 336–7.CrossRefPubMed
Metadaten
Titel
CNS Involvement in Pancreatic Adenocarcinoma: a Report of Eight Cases from the Johns Hopkins Hospital and Review of Literature
verfasst von
Abhijeet Kumar
Meenakshi Dagar
Joseph Herman
Christine Iacobuzio-Donahue
Dan Laheru
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 1/2015
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-014-9667-y

Weitere Artikel der Ausgabe 1/2015

Journal of Gastrointestinal Cancer 1/2015 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.